Long-term treatment with low molecular weight heparin of chronic disseminated intravascular coagulation;Tratamiento a largo plazo de coagulación intravascular diseminada crónica con heparina de bajo peso molecular

Anales de Medicina Interna

Volumn 20, Issue 4, 2003, Pages 191-194

  García Fernández ́n, José Ramo ^a   Lopez Berenguel F ^a   Ais, C ^a  

^a Hospital General Basico de Baza   (Spain)

Author keywords

Aortic aneurysm; Disseminated intravascular coagulation; Low molecular weight heparin; Treatment

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PLASMIN; THROMBIN;

AGED; AORTA ANEURYSM; ARTICLE; BLEEDING; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG HYPERSENSITIVITY; HUMAN; LONG TERM CARE; OSTEOPOROSIS; TREATMENT OUTCOME;

EID: 0037544294     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Seligsohn U. Disseminated intravascular coagulation. In; Bbeutler E, Lichtman MA, Coller BS, Kipps TJ (editors). Hematology. New York: McGraw-Hill Inc; 1995. p.1497-516.
2. Staudinger T, Locker GJ, Frass M. Management of acquired coagulation disorders in emergency and intensive-care medicine. Semin Thromb Hemost 1996; 22: 93-104.
3. Rocha E, Paramo JA, Montes R, Panizo C. Acute generalized, widespread bleeding. Diagnosis and management. Haematologica 1998; 83: 1024-37.
4. de Jonge E, Levi M, Stoutenbeek CP, van Deventer SJ. Current drug treatment strategies for disseminated intravascular coagulation. Drugs 1998; 55: 767-77.
5. Riewald M, Riess H. Treatment options for clinically recognized disseminated intravascular coagulation. Semin Thromb Hemost 1198; 24: 53-9.
6. Amstutz P, Moyo JS. Disseminated intravascular coagulations. Cah Anesthesiol 1996; 44: 219-28.
7. Carey MJ, Rodgers GM. Disseminated intravascular coagulation: clinical and laboratory aspects. Am J Hematol 1998; 59: 65-73.
8. Kitchens CS. Disseminated intravascular coagulation. Curr Op Hematol 1995; 2: 402-6.
9. Colman RW, Robboy SJ, Minna JD. Disseminated intravvascular coagulation: a reappraisal. Annu Rev Med 1979; 30: 359-74.
10. Spero JA, Lewis JH, Hsiba V. Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemostas 1980; 43: 28-33.
11. Bauer K, ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD. Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 1989; 74: 165-72.
12. Feinstein D. Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood 1982; 86: 284-7.
13. Vinazzer HA. Antithrombin III in shock and disseminated intravascular coagulation. Clin Appl Thromb 1995; 12: 62-5.
14. Ziegler EJ, McCutchan JA, Fierer J. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Esherichia coli. N Engl J Med 1982; 307: 1225-30.
15. Fisher CJ, Agosti JM, Opal SM. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N Engl J Med 1996; 334: 1697-702.
16. Warrel R, Kempin S. Treatment of severe coagulopathy in the Kasabach-Merrit syndrome with aminocaproic acid and cryoprecipitate. N Engl J Med 1985; 313: 309-12.
17. Fine NL, Applebaum J, Elguezabal A, Castleman L. Multiple coagulation defects in association with dissecting aneurysm. Arch Intern Med 1967; 119: 522-6.
18. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-42.
19. Audibert G, Lambert H, Toulemonde F. Utilisation d'une héparine de has poids moléculaire, la CY 222, dans le traitment des coagulopathies de consommation. J Mal Vasc 1987; 12 Supl. B: 147-51.
20. Gillis S, Dann EJ, Eldor A. Low molecular weight heparin in the prophylaxis and treatment of disseminated intravascular coagulation in acute promyelocytic leukemia. Eur J Haematol 1995; 54: 59-60.
21. Sakuragawa N, Hasegawa H, Maki M, Oguma Y, Nakagawa M. Clinical evaluation of low-molecular-weight-heparin (FR-860) on disseminated intravascular coagulation (DIC)- a multicenter co-operative double-blind trial in comparison with heparin. Thromb Res 1993; 72: 475-500.